2024 Agenda

 

Tuesday, October 8, 2024

 

8:00am  Registration Opens
9:00am  

  Welcoming Remarks & Opening Plenary Session:
  C-Suite Perspective on Raising Funds and   Structuring Deals in the Current Market

 Moderator: Ben Kromnick, Head of Healthcare and Life   Sciences, Mercury

  • J. Robert Coleman, PhD, CEO, Hervolution
  • Matthew Kittay, MBA, Partner, Fox Rothschild
  • Maria Luisa Pineda, PhD, CEO, Envisagenics.
  • Gerardo Ubaghs, CFO, Frontier Medicines

10:00am 

  Emerging Company Showcase – Session 1
 Sponsored by Mercury
 10:00 AM: Omios Biologics
 10:15 AM: SiVEC Biotechnologies, Inc. 
 10:30 AM: Regenosine
10:00am

 Emerging Company Showcase – Session 2
 Sponsored by Withum
 10:00 AM: Yaso Therapeutics Inc
 10:15 AM: Plakous Therapeutics, Inc.
 10:30 AM: Exposome Therapeutics 
 10:00am   Partnering Forum
 11:00am  Emerging Company Showcase – Session 3
 Sponsored by Mercury
 11:00 AM: Cell BioEngines, Inc. 
 11:15 AM: Cellinfinity Bio
 11:30 AM: iCell Gene Therapeutics
 11:00am  Emerging Company Showcase – Session 4
 Sponsored by Withum
 11:00 AM: Prolocor
 11:15 AM: InLighta Biosciences
12:15pm  

 Luncheon Plenary Session: Building   Therapeutics for the New Decade: Precision   Medicine vs. Mega-Blockbusters
 Moderator: Michael Baran, PhD, Partner, Pfizer   Ventures;  Executive Director WRDM, Pfizer

 Panelists:

  • Troy André, PhD, SVP, Business Innovation, Lead, Commercial Strategy & Innovation, Pfizer, Inc.
  • Brian Busser, PhD, Founder and SVP, R&D, Enceladus Bio
  • Gaurav Gupta, MD, Managing Partner, Life Sciences Private Capital, J.P. Morgan Asset Management
  • R. Nolan Townsend, CEO, Lexeo Therapeutics
  • Gaurav Shah, MD, CEO, Rocket Pharma
 1:15pm

 Venture Spotlight: Next Generation Advanced   Therapies
  Moderator: Michael Norsen, Vice President Alexandria     LaunchLabs NYC & Alexandria Venture Investments
 Panelists:

  • Michael Aberman, MD, General Partner, Regeneron Ventures
  • Megan McGill, MD, PhD, CEO, Epitor Therapeutics
  • Remo Moomiaie-Qajar, MD, Founder and CEO, Cytonus Therapeutics
  • Xinchen Wang, PhD, Co-Founder & CEO, Waypoint Bio
1:15pm   Partnering Forum
2:15pm

 Emerging Company Showcase – Session 5
 Sponsored by Mercury
 2:15 PM: Epitor Therapeutics
 2:30 PM: Cytonus Therapeutics
 2:45 PM: Waypoint Bio
2:15pm    Emerging Company Showcase – Session 6
 Sponsored by Withum
 2:15 PM: EpiVario Inc
 2:30 PM: Rebel Medicine Inc
 2:45 PM: Kannalife Sciences, Inc.
3:15pm  

 Plenary: The Shifting Dynamics of Strategic Deal   Making

 Moderator: Dawn Bell, PharmD, CEO, Antlia Bioscience,   Founder and Director, Myracle Therapeutics

 Panelists:

  • Eva Chmielnicki, PhD, Senior Director, Business Development, Bristol Myers Squibb
  • Sanford J. Madigan, PhD, Managing Partner, Avalon BioVentures 
  • Rachel Mears, Partner, Jeito Capital
  • Marian Nakada, PhD, VP Venture Investment, Johnson & Johnson Innovation 
4:15pm 

 Fireside Chat: Tales From The Trenches: Creating   Value In Early-Stage Drug Discovery

  • Dawn Bell, PharmD, CEO, Antlia Bioscience, Founder and Director, Myracle Therapeutics, Board Member, NewYorkBio
  • Lazar Bojic, PhD, Head, Investor Network, Curie.Bio
5:00pm 

 Networking Reception 

 

Wednesday, October 9, 2024

8:00am   Registration Opens
9:00am  

 Opening Plenary Session:Rethinking Biotech Go-   to-Market Strategies for Success: The IRA’s   Ripple Effect

 Moderator: Adrian Charbin, PhD, Executive Director   Solid  Tumor Strategy, Novartis

 Panelists:

  • Ava Bousher, DVM, PharmD, Senior Director-US and Global Pricing, Reimbursement, and Market Access Strategist, Pfizer
  • Lawrence Monoson, MSc, Co-founder, RXData
  • Pete Vaccaro, Partner, Formulary Insights
  • Anton Xavier, MBA, Director, Silicon Valley Bank

10:00am 

 Emerging Company Showcase – Session 7 
 Sponsored by Mercury
 10:00 AM: 7 Hills Pharma Inc.
 10:15 AM: Frezent Biological Solutions
 10:30 AM: Inomagen Therapeutics, Inc.
10:00am 

 Emerging Company Showcase – Session 8
 Sponsored by Withum
 10:00 AM: TETmedical, Inc.
 10:15 AM: ZBeats
 10:30 AM: Predictably Human, Inc
 10:00am   Partnering Forum
 11:00am  Emerging Company Showcase – Session 9
 Sponsored by Mercury
 11:00 AM: Calder Biosciences Inc.
 11:15 AM: Flag Bio, Inc.
 11:30 AM: Terra Bioforge
 11:00am  Emerging Company Showcase – Session 10
 Sponsored by Withum
 11:00 AM: Avanti Biosciences
 11:15 AM: Egret Therapeutics Inc.
12:00pm  Luncheon
 1:00pm

 Venture Spotlight: Bioconvergence Platform
 Moderator: Pavan Choksi, Partner at Arkitekt Ventures

 Panelists:

  • Lazar Bojic, PhD, Head, Investor Network, Curie.Bio
  • Orly Levitan, PhD VP Partnerships and Business Development, Pragma Bio
  • Isaac Stoner, Director, Co-founder & CEO, Octagon Therapeutics
  • Adam Yaari, PhD, Co-Founder & CEO, Serinus.Bio
1:00pm   Partnering Forum
2:00pm  Emerging Company Showcase – Session 11 
 Sponsored by Mercury
 2:00PM: Pragma
 2:15 PM: Octagon Therapeutics
 2:30 PM: Serinus

2:00pm  

 Emerging Company Showcase – Session 12
 Sponsored by Withum
 2:00PM: Energesis Pharmaceuticals Inc
 2:15 PM: Perpetual Bio
 2:30 PM: Kadence Bio
3:00pm  

 Closing Plenary: Investor Roundtable
 Moderator: Jonathan Fassberg, MBA, Managing Partner,   Astr Partners

 Panelists:

  • Bridget Martel, MA, MD, Operating Partner, Biotechnology, Two Bear Capital
  • John Prufeta, General Partner, Medical Excellence Capital, LLC
  • Uciane Scarlett, PhD, Principal, MPM Capital
  • Joel Sendek, Managing Director, Head of Healthcare Life Sciences Research, Oppenheimer & Co. Inc.
  • Nimish Shah, MBA, MPH, Partner, Venrock
4:00pm 

 Closing Networking